COGNITION THERAPEUTICS, INC. 2021 EQUITY INCENTIVE PLAN STOCK OPTION GRANT NOTICE AND AWARD AGREEMENTAward Agreement • July 29th, 2021 • Cognition Therapeutics Inc • Biological products, (no disgnostic substances) • Delaware
Cognition Therapeutics, Inc., a Delaware corporation (the “Company”), pursuant to its 2021 Equity Incentive Plan (the “Plan”), hereby grants to the individual listed below (“Participant”) an option to purchase the number of Shares set forth below (the “Option”). The Option described in this Stock Option Grant Notice (the “Grant Notice”) is subject to the terms and conditions set forth in the Award Agreement attached hereto as Exhibit A (the “Agreement”) and the Plan, each of which is incorporated herein by reference. Unless otherwise defined herein, capitalized terms used in this Grant Notice and the Agreement will have the meanings defined in the Plan.
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • July 29th, 2021 • Cognition Therapeutics Inc • Biological products, (no disgnostic substances) • Pennsylvania
This Executive Employment Agreement (the “Agreement”), dated ________, 20___, is made and entered into by and between COGNITION THERAPEUTICS, INC., a Delaware corporation (the “Company”) and James O’Brien (“Executive”), and will become effective on the first date that the Company’s common stock is traded on a national stock exchange or national market system (the “Effective Date”).
INDEMNIFICATION AGREEMENTIndemnification Agreement • July 29th, 2021 • Cognition Therapeutics Inc • Biological products, (no disgnostic substances) • Delaware
THIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into effective as of ___, 2021 between Cognition Therapeutics, Inc., a Delaware corporation (the “Company”), and ____ (“Indemnitee”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • July 29th, 2021 • Cognition Therapeutics Inc • Biological products, (no disgnostic substances) • Pennsylvania
This Executive Employment Agreement (the “Agreement”), dated ________, 20___, is made and entered into by and between COGNITION THERAPEUTICS, INC., a Delaware corporation (the “Company”) and Lisa Ricciardi (“Executive”), and will become effective on the first date that the Company’s common stock is traded on a national stock exchange or national market system (the “Effective Date”).
EMPLOYEE Restrictive Covenant AgreemenTEmployee Restrictive Covenant Agreement • July 29th, 2021 • Cognition Therapeutics Inc • Biological products, (no disgnostic substances) • Pennsylvania
THIS AGREEMENT (the “Agreement”) is between Cognition Therapeutics, Inc. (the “Company”), a Delaware corporation with its principal offices at 2500 Westchester Ave., Purchase, NY 10577 and (the “Employee”), an individual residing at the address set forth on the signature page to this Agreement.
